Jeffrey W. Albers, Director at Blueprint Medicines Corp (BPMC), sold 7,500 shares at $87.62 ($659K) on 2025-03-12, disclosed to the SEC on 2025-03-14.
Scheduled sale ($658k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $87.62 | 5,700 | $499K | 75.8% |
| 2 | $88.37 | 1,800 | $159K | 24.2% |
| Total | $87.80 avg | 7,500 | $659K | 100% |
| Filing → |
| KYMR | SELL | 2025-10-14 | $296K | — | Filing → |
| KYMR | SELL | 2025-06-03 | $311K | — | Filing → |
| BPMC | SELL | 2025-05-29 | $572K | — | Filing → |